AM-4030

AM-4030 Structure

Synthetic cannabinoid

AM-4030
[[File:|frameless|220px|alt=|]]
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

AM-4030 is a synthetic cannabinoid that was developed for research purposes. It is structurally related to other cannabinoids and has been studied for its potential effects on the endocannabinoid system.

Chemical Structure

AM-4030 belongs to a class of compounds known as cannabinoids, which interact with the cannabinoid receptors in the brain and body. The chemical structure of AM-4030 includes a dibenzo[b,d]pyran ring system, which is a common feature in many synthetic cannabinoids.

Pharmacology

AM-4030 acts as an agonist at the CB1 and CB2 cannabinoid receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes including pain, mood, and appetite.

Research and Applications

Research on AM-4030 has primarily focused on its interaction with the endocannabinoid system and its potential therapeutic applications. Studies have investigated its effects on pain management, neuroprotection, and anti-inflammatory properties.

Legal Status

The legal status of AM-4030 varies by country. In some jurisdictions, it may be classified as a controlled substance due to its potential for abuse and psychoactive effects.

See Also

• Synthetic cannabinoids
• Endocannabinoid system
• Cannabinoid receptor

References

   This article is a medical stub. You can help WikiMD by expanding it!